Understanding how protein quality control affects blood stem cells
The role of ER associated degradation (ERAD) in hematopoietic stem cells
This study is looking at how a process that helps keep proteins healthy in our cells supports the resting state of blood stem cells, which are important for making new blood cells, especially during tough times, and it hopes to find new ways to help with blood-related diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10850894 on NIH RePORTER |
What this research studies
This research investigates the role of a process called ER associated degradation (ERAD) in maintaining the health and function of hematopoietic stem cells (HSCs), which are crucial for producing blood cells. The study focuses on how protein quality control mechanisms in the endoplasmic reticulum help keep these stem cells in a dormant state, preserving their ability to regenerate blood cells when needed. By examining the effects of ERAD on HSC quiescence and self-renewal, the research aims to uncover the underlying mechanisms that regulate stem cell behavior, particularly under stress conditions. This could lead to new insights into blood diseases and potential therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with blood-related conditions or those undergoing stem cell transplantation.
Not a fit: Patients with non-hematological conditions or those not requiring blood cell regeneration may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for blood disorders by enhancing the function of hematopoietic stem cells.
How similar studies have performed: Other research has shown promising results in understanding stem cell behavior through similar mechanisms, indicating a potential for success in this area.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Li, Qing — University of Michigan at Ann Arbor
- Study coordinator: Li, Qing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.